Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation

    Access Status
    Fulltext not available
    Authors
    Obamiro, K.
    Stafford, Leanne
    Bereznicki, L.
    Date
    2016
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Obamiro, K. and Stafford, L. and Bereznicki, L. 2016. A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation. American Journal of Cardiovascular Drugs. 16 (5): pp. 349-363.
    Source Title
    American Journal of Cardiovascular Drugs
    DOI
    10.1007/s40256-016-0171-6
    ISSN
    1175-3277
    URI
    http://hdl.handle.net/20.500.11937/58497
    Collection
    • Curtin Research Publications
    Abstract

    © 2016, Springer International Publishing Switzerland.Atrial fibrillation (AF) is a growing public health concern and remains an independent risk factor for ischemic stroke. Warfarin, a commonly used oral anticoagulant, is associated with a 60–70 % relative reduction in stroke risk and a reduction in mortality of 26 %. However, warfarin has several limitations, including a narrow therapeutic window, variable dose response, multiple interactions with other drugs and concurrent illnesses, and the need for frequent laboratory monitoring. In recent years, the direct acting oral anticoagulants (DOACs), including dabigatran, rivaroxaban, apixaban and edoxaban, have been developed to overcome the limitations of warfarin therapy. These treatment strategies are either comparable or superior to warfarin in stroke prevention in AF. Despite the documented effectiveness of oral anticoagulants in AF, patients may not derive optimal benefit if they fail to adhere or fail to continue with their medication. This may lead to treatment failure, increased hospitalization and mortality. This review summarizes the literature regarding adherence and persistence (or discontinuation) rates with oral anticoagulants in the management of AF; the impact of non-adherence and non-persistence on treatment outcomes; and the effectiveness of strategies to improve adherence and persistence with oral anticoagulant therapy.

    Related items

    Showing items related by title, author, creator and subject.

    • Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey
      Obamiro, K.; Chalmers, Leanne; Lee, K.; Bereznicki, B.; Bereznicki, L. (2018)
      © 2018 John Wiley & Sons Ltd Background: Atrial fibrillation (AF) is the most commonly diagnosed arrhythmia in clinical practice, and is associated with a significant medical and economic burden. Anticoagulants reduce ...
    • The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015
      Alamneh, E.; Stafford, Leanne; Bereznicki, L. (2017)
      © 2017 John Wiley & Sons Ltd Introduction: Contemporary Australian data regarding antithrombotic prescribing patterns following approval of direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) ...
    • Development and validation of an oral anticoagulation knowledge tool (AKT)
      Obamiro, K.; Stafford, Leanne; Bereznicki, L. (2016)
      © 2016 Obamiro et al.This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.